Royalty Pharma PLC at Goldman Sachs Healthcare Conference Transcript
All right. Let's get right into it -- to our next session. Very excited to have Chris Hite, Chairman of Royalty Pharma, with us, here, today.
Questions & Answers
Chris, maybe just to tee you up, start with, like, a 10,000 feet for those new to the story. Give us a brief history on the evolution of the company; its core pillars; what the fundamental thesis is; and why investors should be looking at Royalty Pharma today.
Sure. Well, first of all, thank you very much for having us here. We're really delighted to be here at the Goldman conference. Great investor meetings today. And so thank you very much.
Royalty Pharma was founded about 30 years ago -- we're celebrating our 30th anniversary -- by our current CEO and Chairman, Pablo Legorreta.
The basic premise back then was, there's fragmented innovation across the sector. That innovation can occur at universities, hospitals, and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
